Portal hypertension
MONDO:0005080Increased blood pressure in the portal venous system. It is most commonly caused by cirrhosis. Other causes include portal vein thrombosis, Budd-Chiari syndrome, and right heart failure. Complications include ascites, esophageal varices, encephalopathy, and splenomegaly.
83 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Early liver shunt may reduce need for repeated fluid drains in ascites patients
Disease control CompletedThis trial compares two approved treatments for ascites (fluid buildup in the belly) caused by portal hypertension. One group receives large-volume paracentesis (draining fluid with a needle) plus albumin infusion, while the other gets an early TIPS procedure, which creates a new…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Antibiotics before endoscopy: necessary or not for cirrhosis patients?
Disease control CompletedThis study looked at whether giving antibiotics before an endoscopic procedure helps prevent fever and rebleeding in people with cirrhosis who have had variceal bleeding before. 226 patients were randomly assigned to receive the antibiotic ceftriaxone or no antibiotics before the…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Robotic surgery spares nerves to cut digestive woes in cirrhosis
Disease control CompletedThis study tested a new robotic surgery technique that protects the vagus nerve during spleen removal and blood vessel disconnection in 60 cirrhosis patients with portal hypertension. The goal was to see if it reduces common side effects like diarrhea and delayed stomach emptying…
Phase: NA • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Computer model may help tailor blood pressure meds for liver patients
Disease control CompletedThis study tested whether a computer program (Simcyp) could predict the right doses of two blood pressure drugs, nebivolol and carvedilol, for people with liver cirrhosis and high blood pressure. Forty patients were randomly assigned to one of the two drugs and monitored for thre…
Phase: PHASE4 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Cheaper stents vs. pricier ones: which is better value for liver patients?
Disease control CompletedThis study looked at two types of stents used in a procedure called TIPS, which creates a bypass in the liver to relieve complications of cirrhosis. One stent is covered with a special material to stay open longer but costs more; the other is a standard bare stent that is cheaper…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?
Diagnosis CompletedThis study tests whether the inferior vena cava (the body's main vein) can serve as a reliable reference point for measuring blood pressure in the liver during an endoscopic ultrasound. Normally, doctors use a hepatic vein for this, but in people with advanced liver scarring, tho…
Sponsor: University Hospital Muenster • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
Could a quick ultrasound replace painful liver biopsies for kids?
Diagnosis CompletedThis study tested whether a noninvasive device called FibroScan can accurately measure liver scarring (fibrosis) in children, potentially replacing the need for a liver biopsy. Researchers compared FibroScan results with biopsy results in 264 children aged 6 months to 18 years wi…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Tai-Chi and lactulose combo tested to stop falls in liver patients
Prevention CompletedThis completed Phase 3 trial tested whether a combination of lactulose (a medicine) and virtual Tai-Chi (a gentle exercise) could reduce falls and other serious events in 230 people with cirrhosis and portal hypertension. Participants were randomly assigned to different sequences…
Phase: PHASE3 • Sponsor: University of Michigan • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
Stent procedure eases severe symptoms in cancer patients with blocked veins
Symptom relief CompletedThis study looked at placing a small metal tube (stent) into the portal vein of 63 cancer patients whose vein was blocked by a tumor. The goal was to relieve serious symptoms like fluid buildup in the belly or bleeding in the gut. The procedure was done through a needle in the li…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Small study aims to unlock secrets of rare lung disease
Knowledge-focused CompletedThis completed Phase 1 study looked at 27 people with and without pulmonary hypertension to learn more about how blood vessel problems contribute to the disease. Researchers used heart catheterization, imaging, and blood tests to find biomarkers and understand disease mechanisms.…
Phase: PHASE1 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
New scope method challenges standard liver biopsy
Knowledge-focused CompletedThis study compared two procedures for getting a liver biopsy and measuring liver pressure in people with chronic liver disease or cirrhosis. One method uses a scope through the mouth (endoscopic ultrasound), the other goes through a vein in the neck (transjugular). The goal was …
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Hidden brain fog in liver disease: new study sheds light
Knowledge-focused CompletedThis study looked at 82 adults with cirrhosis and portal hypertension (high blood pressure in the liver) to find out how many have minimal hepatic encephalopathy (MHE) — a mild form of brain fog that can affect thinking. Researchers used simple blood tests and thinking exercises …
Phase: NA • Sponsor: IHU Strasbourg • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Computer-Guided statin dosing shows promise for liver patients
Knowledge-focused CompletedThis study tested whether a computer program could help doctors choose the right dose of simvastatin for people with cirrhosis and high blood pressure in the liver. Twenty-two patients received either 5 mg or 15 mg of simvastatin daily for three months. Researchers measured chang…
Phase: PHASE4 • Sponsor: Kafrelsheikh University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC